Nylim GBL Ety R&D LDR ETF-UiWRNDETF
13F holders, Q2 2024 (June 30)4holders
0new positions
0sold out
$29.40avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($5.6M), GTS Securities LLC ($556K) and UBS Group AG ($2K).
- Company
- Nylim GBL Ety R&D LDR ETF-Ui
- Filed as
- INDEXIQ ETF TR (Q2 2024)
- CUSIP
- 45409B255
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 1,065 shares bought, net +1,065 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $5.6M |
| GTS Securities LLC | 0.01% | Add +6.0% | 18,905 | $556K |
| UBS Group AG | 0.00% | No change | 70 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 11 | $323 |
"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.